INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $416,625 | +40.8% | 16,500 | +22.0% | 0.00% | – |
| Q3 2022 | $296,000 | -41.3% | 13,530 | -13.3% | 0.00% | – |
| Q1 2021 | $504,000 | +80.6% | 15,600 | +90.2% | 0.00% | – |
| Q4 2020 | $279,000 | -56.7% | 8,200 | -78.2% | 0.00% | -100.0% |
| Q1 2020 | $644,000 | -53.0% | 37,600 | -35.7% | 0.00% | -33.3% |
| Q4 2019 | $1,371,000 | +101.6% | 58,500 | +57.3% | 0.00% | +50.0% |
| Q3 2019 | $680,000 | -33.6% | 37,200 | -7.0% | 0.00% | -33.3% |
| Q2 2019 | $1,024,000 | -11.7% | 40,000 | +0.3% | 0.00% | -25.0% |
| Q1 2019 | $1,160,000 | -6.5% | 39,900 | -34.9% | 0.00% | +33.3% |
| Q3 2018 | $1,240,000 | -37.2% | 61,300 | -30.0% | 0.00% | -25.0% |
| Q2 2018 | $1,973,000 | 0.0% | 87,607 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,973,000 | +52.5% | 87,607 | +111.1% | 0.00% | 0.0% |
| Q4 2017 | $1,294,000 | -80.4% | 41,500 | -80.3% | 0.00% | -84.0% |
| Q3 2017 | $6,588,000 | +973.0% | 211,100 | +240.0% | 0.02% | +525.0% |
| Q2 2016 | $614,000 | – | 62,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |